Clements JD - Search Results

1

Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

Rollwagen FM, Pacheco ND, Clements JD, Pavlovskis O, Rollins DM, Walker RI. Rollwagen FM, et al. Among authors: clements jd. Vaccine. 1993 Oct;11(13):1316-20. doi: 10.1016/0264-410x(93)90101-3. Vaccine. 1993. PMID: 8296484

2

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

Clements JD, Hartzog NM, Lyon FL. Clements JD, et al. Vaccine. 1988 Jun;6(3):269-77. doi: 10.1016/0264-410x(88)90223-x. Vaccine. 1988. PMID: 3048010

3

Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers.

Cárdenas L, Dasgupta U, Clements JD. Cárdenas L, et al. Among authors: clements jd. Vaccine. 1994 Jul;12(9):833-40. doi: 10.1016/0264-410x(94)90293-3. Vaccine. 1994. PMID: 7975861

4

Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors.

Cárdenas L, Clements JD. Cárdenas L, et al. Among authors: clements jd. Vaccine. 1993;11(2):126-35. doi: 10.1016/0264-410x(93)90007-k. Vaccine. 1993. PMID: 8382417

5

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

Chong C, Friberg M, Clements JD. Chong C, et al. Among authors: clements jd. Vaccine. 1998 Apr;16(7):732-40. doi: 10.1016/s0264-410x(97)00255-7. Vaccine. 1998. PMID: 9562694

6

Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.

Mason HS, Haq TA, Clements JD, Arntzen CJ. Mason HS, et al. Among authors: clements jd. Vaccine. 1998 Aug;16(13):1336-43. doi: 10.1016/s0264-410x(98)80020-0. Vaccine. 1998. PMID: 9682399 Free article.

7

The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).

Cheng E, Cárdenas-Freytag L, Clements JD. Cheng E, et al. Among authors: clements jd. Vaccine. 1999 Aug 20;18(1-2):38-49. doi: 10.1016/s0264-410x(99)00168-1. Vaccine. 1999. PMID: 10501233

8

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G).

Morris CB, Cheng E, Thanawastien A, Cárdenas-Freytag L, Clements JD. Morris CB, et al. Among authors: clements jd. Vaccine. 2000 Mar 17;18(18):1944-51. doi: 10.1016/s0264-410x(99)00447-8. Vaccine. 2000. PMID: 10699345

9

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants.

McCluskie MJ, Weeratna RD, Clements JD, Davis HL. McCluskie MJ, et al. Among authors: clements jd. Vaccine. 2001 Jun 14;19(27):3759-68. doi: 10.1016/s0264-410x(01)00088-3. Vaccine. 2001. PMID: 11395211

10

Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response.

Morris CB, Thanawastien A, Sullivan DE, Clements JD. Morris CB, et al. Among authors: clements jd. Vaccine. 2001 Oct 12;20(1-2):12-5. doi: 10.1016/s0264-410x(01)00271-7. Vaccine. 2001. PMID: 11567739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters